Published 10-25-22
Submitted by Illumina
Originally published on Illumina News Center
SAN DIEGO, October 25, 2022 /CSRwire/ - Illumina, Inc. (NASDAQ: ILMN) announced that it will host its second annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:30 am Pacific Time (12:30 pm Eastern Time), Friday, October 28, 2022.
Francis deSouza, President and Chief Executive Officer, Aimee Hoyt, Chief People Officer, John Frank, Chief Public Affairs Officer, and Sharon Vidal, Head of Corporate Social Responsibility, will be joined by Salli Schwartz, Vice President of Investor Relations for a presentation, fireside chat, and Q&A session for investors, analysts, and other interested parties regarding Illumina's ESG strategy and action plans.
Webcast Details
The webcast will begin at 9:30 am Pacific Time (12:30 pm Eastern Time) on Friday, October 28, 2022. Interested parties may register and access the event through the Investor Info section of Illumina's website at investor.illumina.com or directly at Illumina Virtual ESG Investor Event. Attendees may submit questions in advance on the registration page.
To ensure timely connection, please join the webcast at least ten minutes before the scheduled start. A replay of the webcast will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:
Salli Schwartz
858-291-6421
IR@illumina.com
Media:
David McAlpine
347-327-1336
PR@illumina.com
SOURCE Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
More from Illumina